Patent intelligence · US
US 12084419
Cell metabolism modulating compounds and uses thereof
Cell metabolism modulating compounds and uses thereof
Patent details — US 12084419
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 10, 2024
- Expiration
- Sep 5, 2044
- Applicant
- CRESCENTA BIOSCIENCES
- Claims
- 44
- CPC classes
- A61K, A61K45/06, A61P, A61P3/10
Quick answer
US 12084419 (Cell metabolism modulating compounds and uses thereof) is held by CRESCENTA BIOSCIENCES. Status: granted. Granted Sep 10, 2024. Expires Sep 5, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- CRESCENTA BIOSCIENCES
- Grant date
- Expiration
- Claims
- 44
- CPC classes
- A61K, A61K45/06, A61P, A61P3/10
More from CRESCENTA BIOSCIENCES
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 12084419?
US 12084419 (Cell metabolism modulating compounds and uses thereof) is held by CRESCENTA BIOSCIENCES. Status: granted. Granted Sep 10, 2024. Expires Sep 5, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12084419?
CRESCENTA BIOSCIENCES is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does US 12084419 expire?
Our index shows an expiration date of Sep 5, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.